Logo image of BCOW

1895 BANCORP OF WISCONSIN IN (BCOW) Stock Fundamental Analysis

NASDAQ:BCOW - Nasdaq - US28253R1059 - Common Stock - Currency: USD

9.4  -0.7 (-6.93%)

After market: 9.71 +0.31 (+3.3%)

Fundamental Rating

2

Overall BCOW gets a fundamental rating of 2 out of 10. We evaluated BCOW against 394 industry peers in the Banks industry. While BCOW seems to be doing ok healthwise, there are quite some concerns on its profitability. BCOW is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BCOW has reported negative net income.
BCOW had a negative operating cash flow in the past year.
In multiple years BCOW reported negative net income over the last 5 years.
BCOW had a positive operating cash flow in 4 of the past 5 years.
BCOW Yearly Net Income VS EBIT VS OCF VS FCFBCOW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M -4M -6M

1.2 Ratios

BCOW has a Return On Assets of -0.58%. This is amonst the worse of the industry: BCOW underperforms 95.77% of its industry peers.
BCOW has a Return On Equity of -4.46%. This is amonst the worse of the industry: BCOW underperforms 95.27% of its industry peers.
Industry RankSector Rank
ROA -0.58%
ROE -4.46%
ROIC N/A
ROA(3y)-0.41%
ROA(5y)-0.17%
ROE(3y)-3.14%
ROE(5y)-1.29%
ROIC(3y)N/A
ROIC(5y)N/A
BCOW Yearly ROA, ROE, ROICBCOW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 4 -4 -6 -8

1.3 Margins

BCOW does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BCOW Yearly Profit, Operating, Gross MarginsBCOW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

More info and screens

5

2. Health

2.1 Basic Checks

BCOW does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BCOW has less shares outstanding
BCOW has less shares outstanding than it did 5 years ago.
There is no outstanding debt for BCOW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BCOW Yearly Shares OutstandingBCOW Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
BCOW Yearly Total Debt VS Total AssetsBCOW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

BCOW has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC9.52%
BCOW Yearly LT Debt VS Equity VS FCFBCOW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BCOW Yearly Current Assets VS Current LiabilitesBCOW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M

More info and screens

0

3. Growth

3.1 Past

BCOW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.63%, which is quite impressive.
The Revenue has decreased by -5.58% in the past year.
The Revenue has been decreasing by -6.68% on average over the past years.
EPS 1Y (TTM)27.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.56%
Revenue 1Y (TTM)-5.58%
Revenue growth 3Y-17.14%
Revenue growth 5Y-6.68%
Sales Q2Q%148.73%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BCOW Yearly Revenue VS EstimatesBCOW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BCOW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BCOW Price Earnings VS Forward Price EarningsBCOW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BCOW Per share dataBCOW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BCOW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

1895 BANCORP OF WISCONSIN IN

NASDAQ:BCOW (3/7/2025, 8:06:58 PM)

After market: 9.71 +0.31 (+3.3%)

9.4

-0.7 (-6.93%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)11-08 2024-11-08/amc
Earnings (Next)03-27 2025-03-27
Inst Owners30.29%
Inst Owner Change0%
Ins Owners4.57%
Ins Owner Change0%
Market Cap56.02M
Analysts0
Price TargetN/A
Short Float %0.07%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.24
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 0.78
EV/EBITDA N/A
EPS(TTM)-0.59
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS2.22
BVpS12.28
TBVpS12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.58%
ROE -4.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-0.41%
ROA(5y)-0.17%
ROE(3y)-3.14%
ROE(5y)-1.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 45.63%
Cap/Sales 1.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC9.52%
ROIC/WACCN/A
Cap/Depr(3y)77.88%
Cap/Depr(5y)74.66%
Cap/Sales(3y)3.34%
Cap/Sales(5y)3.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.58%
Revenue growth 3Y-17.14%
Revenue growth 5Y-6.68%
Sales Q2Q%148.73%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y96.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.28%
OCF growth 3YN/A
OCF growth 5YN/A